Press "Enter" to skip to content

British Columbia to be first Canadian province to switch patients to biosimilars

The Canadian province of British Columbia said on Monday that its public drug plan will switch as many as 20,400 patients from three branded biologic drugs to cheap near-copies called biosimilars, saving an estimated C$96.6 million ($71.9 million)over three years.

Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/8pj5WeAA-GM/british-columbia-to-be-first-canadian-province-to-switch-patients-to-biosimilars-idINKCN1SX1VS

Also Read:   UK hospital told to prepare for Oxford Covid vaccine in November: Report